Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > Upstream Processing

PharmaCell to make autologous cell therapies for Lion Biotech

28-Apr-2017 - Dutch contract manufacturer PharmaCell B.V has signed a three-year Manufacturing Services Agreement to make cancer cell therapies for Lion Biotechnologies.


Boehringer Ingelheim upping capacity with €700m mammalian cell culture plant

27-Apr-2017 - Boehringer Ingelheim has broken ground on a €700m stainless steel bioproduction facility set to house 135,000L of mammalian cell culture capacity.

United BioPharma selects GE Healthcare’s FlexFactory for Taiwan HIV drug plant

27-Apr-2017 - United BioPharma Inc. (UBP), with government backing, has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu Industrial Park, Taiwan.


Getting a feel for biomanufacturing at the Biotech Training Facility

25-Apr-2017 - Hands-on teaching offers drugmakers, vendors and regulators a better understanding of bioprocessing, according to the managing director of a training facility in Leiden, The Netherlands.

BPI Europe 2017: Biomanufacturing industry goes Dutch

25-Apr-2017 - The bioprocessing industry has donned its clogs and made its way to Amsterdam. And Biopharma-Reporter is here too, bringing you the best of BPI Europe 2017.

BioInvent buys Merck single-use tech to up mAb capacity

21-Apr-2017 - BioInvent International AB has acquired a range of different single-use bioreactors from Germany’s Merck to up monoclonal antibody (mAb) capacity at its plant in Lund, Sweden.

Sartorius Stedim Biotech announces French government-backed R&D project

21-Apr-2017 - Sartorius Stedim Biotech (SSB) has announced a €23m ($24.6m) research and development (R & D) programme with funding from local government bodies La Region Provence-Alpes-Cote d’Azur and la Metropole Aix-Marseille...


Hey big vendor... Is bioprocessing consolidation good for the end-user?

19-Apr-2017 - Price hikes and lack of innovation, or better buying power and end-to-end services? Experts are split on supplier M&A and its effect on biomanufacturers.

Cobra to boost gene therapy and CAR-T capacity through £15m investment

18-Apr-2017 - Cobra Biologics has said it will spend £15m ($19m) to increase gene therapy production capacity, citing customer demand and market opportunities.

Fujifilm invests $130m in CDMO business, ups mammlian bioreactor capacity 70%

18-Apr-2017 - Fujifilm has invested around $130m into facilities in the US and UK weeks after launching its biopharma CDMO business.

Speed, yield and quality critical for cell line development, says ATUM

12-Apr-2017 - ATUM has launched itself into the mammalian cell line development space after being awarded patents for its Leap-In transposase genome technology.

GE Healthcare teams with CBMG to develop CAR-T and stem cell production tech

11-Apr-2017 - GE Healthcare has agreed to help Cellular Biomedicine Group (CBMG) develop CAR-T and stem cell production technologies to support its aim of making 10,000 cancer cell therapies a year. 

Sumitomo Dainippon buys cell therapy processing tech from Hitachi

10-Apr-2017 - Sumitomo Dainippon Pharma Co Ltd has ordered cell culture technologies from Hitachi as part of its effort to develop a treatment for Parkinson’s disease.

1st Stem Cell Community Day - Hamburg, Germany

Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts

07-Apr-2017 - The only practical way to scale-up volumes of mesenchymal stem cells (MSCs) is by using microcarriers in single-use bioreactors, say scientists from A*STAR and Instituto Superior Técnico.

Dispatches from the 1st Stem Cell Community Day, Hamburg

UK Catapult: QbD and process automation key for making commercial cell therapies

05-Apr-2017 - Process automation should be incorporated early when developing large scale cell therapy manufacturing platforms, according to a lead scientist from the UK Catapult.

Sartorius buys its PAT and QbD software partner for $72.5m

04-Apr-2017 - A new month and a new acquisition for Sartorius which has bought its biomanufacturing data analytics software partner for $72.5m (€68m).

Agenus trimming 50 jobs as it focuses on cancer vaccines and antibodies

31-Mar-2017 - Immuno-oncology antibody and vaccine firm Agenus Inc will close a site in Basel and axe 50 jobs as part of a reorganisation.

'One-litre bioreactor scale currently the maximal for stem cell expansion and differentiation'

Industry needs new bioreactor and monitoring tech for stem cell scale-up, expert

24-Mar-2017 - Stem cell therapy developers are lacking production scale-up technologies, says the chair of an upcoming conference bringing industry and academia together to address the problem.

Caladrius: 'Hitachi will unlock full potential of cell therapy CDMO PCT'

24-Mar-2017 - Hitachi Chemical Co. America will increase its presence in the cell therapy development and manufacturing space through the $75m acquisition of Caladrius Biosciences subsidiary PCT.

GSK breaks ground on $175m German Bexsero vaccine facility

21-Mar-2017 - GlaxoSmithKline has broken ground on a €162m ($175m) meningococcal B vaccine production plant in Germany.

Trailer Park Bios? Germfree wheels out mobile cleanroom to fill production gaps

14-Mar-2017 - Florida, US-based aseptic control and biosafety services firm Germfree has launched the latest in its mobile cleanrooms, the Mobile Adaptive Bioproduction Suite.

Horizon inks optimisation tech deal for next generation CHO K1 cell line

10-Mar-2017 - Horizon Discovery Group has teamed up with Amplycell to optimise its GS (glutamine synthetase) null CHO K1 cell line.

BeiGene forms JV to build biologics plant in Guangzhou

08-Mar-2017 - BeiGene Ltd has said it will build a biologics manufacturing plant in collaboration with Guangzhou Development District (GDD).

Fetal attraction? FBS supplier offers price guarantee for 'cell food' mainstay

03-Mar-2017 - Lot-to-lot consistency is key for fetal bovine serum (FBS) supply, says Nucleus Biologics which is offering clients stable volumes and prices on its single-sourced serum.

Jazz: 24/7 production shifts could help stem Erwinaze shortage

01-Mar-2017 - Non-stop production shifts are among initiatives being tested by Jazz Pharmaceuticals to up supply of orphan drug Erwinaze after its CMO received an FDA warning letter.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...